• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌在化疗所致腹泻管理中的应用:一项病例研究

Use of probiotics in the management of chemotherapy-induced diarrhea: a case study.

作者信息

Abd El-Atti Samia, Wasicek Kelley, Mark Scott, Hegazi Refaat

机构信息

University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, and University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.

出版信息

JPEN J Parenter Enteral Nutr. 2009 Sep-Oct;33(5):569-70. doi: 10.1177/0148607109332004. Epub 2009 May 7.

DOI:10.1177/0148607109332004
PMID:19423769
Abstract

Gastrointestinal disturbances (particularly diarrhea) are often induced in response to cancer treatments such as chemotherapy or radiation. Oral chemotherapeutic agents can induce diarrhea by damaging the intestinal lining. Two common oral drugs used in cancer treatment that are known to have gastrointestinal side effects are capecitabine and lapatinib. In this brief communication, the authors discuss a case study of a stage IV breast cancer patient whose chemotherapy-induced diarrhea was treated successfully with a multispecies combination of probiotics. This is a unique study in which grade 3 chemotherapy-induced diarrhea (characterized by 7-9 stools per day and associated with incontinence and abdominal cramping) was treated with only a multispecies combination of probiotics. Probiotics have been used to treat diarrhea in patients with irritable bowel syndrome, ulcerative colitis, pouchitis, and Crohn's disease. More recently, probiotics have been used to treat chemotherapy-induced diarrhea in colon cancer patients. This case study demonstrates that the probiotics can also be used to treat severe cases of chemotherapy-induced diarrhea in breast cancer patients. The use of different probiotics in gastrointestinal diseases is an increasingly important area of study, and more research into this area is needed. This study demonstrates that probiotics should be considered for advanced breast cancer patients with chemotherapy-induced diarrhea.

摘要

胃肠道紊乱(尤其是腹泻)常常是对化疗或放疗等癌症治疗的反应。口服化疗药物可通过损伤肠壁诱发腹泻。已知在癌症治疗中使用的两种常见口服药物卡培他滨和拉帕替尼具有胃肠道副作用。在这篇简短的通讯中,作者讨论了一例IV期乳腺癌患者的病例研究,该患者化疗引起的腹泻通过多种益生菌组合成功治愈。这是一项独特的研究,其中3级化疗引起的腹泻(其特征为每天排便7 - 9次,并伴有大便失禁和腹部绞痛)仅用多种益生菌组合进行治疗。益生菌已被用于治疗肠易激综合征、溃疡性结肠炎、袋炎和克罗恩病患者的腹泻。最近,益生菌已被用于治疗结肠癌患者化疗引起的腹泻。该病例研究表明,益生菌也可用于治疗乳腺癌患者严重的化疗引起的腹泻。在胃肠道疾病中使用不同的益生菌是一个日益重要的研究领域,对此领域需要进行更多研究。这项研究表明,对于患有化疗引起腹泻的晚期乳腺癌患者应考虑使用益生菌。

相似文献

1
Use of probiotics in the management of chemotherapy-induced diarrhea: a case study.益生菌在化疗所致腹泻管理中的应用:一项病例研究
JPEN J Parenter Enteral Nutr. 2009 Sep-Oct;33(5):569-70. doi: 10.1177/0148607109332004. Epub 2009 May 7.
2
Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer.一项新型卡培他滨给药方案联合拉帕替尼治疗人表皮生长因子受体 2 阳性转移性乳腺癌的 II 期临床试验。
Breast Cancer Res Treat. 2012 Jan;131(1):111-6. doi: 10.1007/s10549-011-1749-y. Epub 2011 Sep 4.
3
[Palliative chemotherapy for metastatic breast cancer with capecitabine].[卡培他滨用于转移性乳腺癌的姑息化疗]
Gan To Kagaku Ryoho. 2009 May;36(5):769-72.
4
Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes.一项评估口服长春瑞滨联合卡培他滨作为蒽环类和紫杉类药物治疗失败的转移性乳腺癌二线治疗的Ⅱ期临床研究。
Cancer Chemother Pharmacol. 2010 Mar;65(4):755-63. doi: 10.1007/s00280-009-1081-y. Epub 2009 Aug 9.
5
A phase I study of capecitabine, oxaliplatin, and lapatinib in metastatic or advanced solid tumors.卡培他滨、奥沙利铂和拉帕替尼治疗转移性或晚期实体瘤的 I 期研究。
Clin Colorectal Cancer. 2011 Mar 1;10(1):57-62. doi: 10.3816/CCC.2011.n.008.
6
Reversible slurred speech related to capecitabine and lapatinib combination in patients with breast cancer.
J Oncol Pharm Pract. 2015 Feb;21(1):72-3. doi: 10.1177/1078155213508442. Epub 2013 Oct 23.
7
Use of probiotics for treatment of chemotherapy-induced diarrhea: is it a myth?使用益生菌治疗化疗引起的腹泻:这是无稽之谈吗?
JPEN J Parenter Enteral Nutr. 2009 Sep-Oct;33(5):573-4. doi: 10.1177/0148607109336596. Epub 2009 Jun 25.
8
FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2.美国食品药品监督管理局药物批准摘要:拉帕替尼联合卡培他滨用于先前接受过治疗的HER-2过表达转移性乳腺癌。
Oncologist. 2008 Oct;13(10):1114-9. doi: 10.1634/theoncologist.2008-0816. Epub 2008 Oct 10.
9
Lapatinib: new drug. For some women with metastatic breast cancer.拉帕替尼:新药。适用于某些转移性乳腺癌女性患者。
Prescrire Int. 2009 Feb;18(99):9.
10
Pooled analysis of diarrhea events in patients with cancer treated with lapatinib.拉帕替尼治疗癌症患者腹泻事件的汇总分析。
Breast Cancer Res Treat. 2008 Nov;112(2):317-25. doi: 10.1007/s10549-007-9860-9. Epub 2008 Jan 20.

引用本文的文献

1
The Microbiome in the Obesity-Breast Cancer Axis: Diagnostic and Therapeutic Potential.肥胖-乳腺癌轴中的微生物组:诊断和治疗潜力
Pathogens. 2023 Nov 29;12(12):1402. doi: 10.3390/pathogens12121402.
2
The effect of an exopolysaccharide probiotic molecule from on breast cancer cells.一种来自……的胞外多糖益生菌分子对乳腺癌细胞的影响。 (注:原文中“from”后面内容缺失)
Front Oncol. 2023 Nov 23;13:1292635. doi: 10.3389/fonc.2023.1292635. eCollection 2023.
3
Milk fermented by Lactobacillus casei CRL431 administered as an immune adjuvant in models of breast cancer and metastasis under chemotherapy.
干酪乳杆菌CRL431发酵的牛奶在化疗条件下的乳腺癌和转移模型中作为免疫佐剂使用。
Appl Microbiol Biotechnol. 2021 Jan;105(1):327-340. doi: 10.1007/s00253-020-11007-x. Epub 2020 Nov 18.
4
Relationship Between the Gut Microbiome and Systemic Chemotherapy.肠道微生物组与全身化疗的关系。
Dig Dis Sci. 2020 Mar;65(3):874-884. doi: 10.1007/s10620-020-06119-3.
5
KLDS1.0318 Ameliorates Impaired Intestinal Immunity and Metabolic Disorders in Cyclophosphamide-Treated Mice.KLDS1.0318改善环磷酰胺处理小鼠的肠道免疫损伤和代谢紊乱。
Front Microbiol. 2019 Apr 12;10:731. doi: 10.3389/fmicb.2019.00731. eCollection 2019.
6
Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities.治疗性细菌对抗癌症:当前进展、挑战和机遇。
Cancer Med. 2019 Jun;8(6):3167-3181. doi: 10.1002/cam4.2148. Epub 2019 Apr 5.
7
Management of Mucositis During Chemotherapy: From Pathophysiology to Pragmatic Therapeutics.化疗期间口腔黏膜炎的管理:从病理生理学到实用治疗学
Curr Oncol Rep. 2015 Nov;17(11):50. doi: 10.1007/s11912-015-0474-9.
8
Diet and nutrition in cancer survivorship and palliative care.癌症康复和姑息治疗中的饮食与营养。
Evid Based Complement Alternat Med. 2013;2013:917647. doi: 10.1155/2013/917647. Epub 2013 Oct 30.
9
Systematic review of agents for the management of gastrointestinal mucositis in cancer patients.系统评价癌症患者胃肠道黏膜炎管理中的药物。
Support Care Cancer. 2013 Jan;21(1):313-26. doi: 10.1007/s00520-012-1644-z. Epub 2012 Nov 10.
10
Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting.TaqMan-PCR、454 测序和 PCR-DGGE 指纹图谱分析化疗引起的人粪便微生物组变化。
PLoS One. 2011;6(12):e28654. doi: 10.1371/journal.pone.0028654. Epub 2011 Dec 14.